Aprogen Medicines Statistics

Total Valuation

KRX:007460 has a market cap or net worth of KRW 206.95 billion. The enterprise value is 554.70 billion.

Market Cap	206.95B
Enterprise Value	554.70B

Important Dates

The last earnings date was Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:007460 has 291.07 million shares outstanding. The number of shares has increased by 12.95% in one year.

Current Share Class	291.07M
Shares Outstanding	291.07M
Shares Change (YoY)	+12.95%
Shares Change (QoQ)	+4.88%
Owned by Insiders (%)	7.35%
Owned by Institutions (%)	2.24%
Float	158.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.49
PB Ratio	0.50
P/TBV Ratio	1.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-12.87
EV / Sales	4.00
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.76

Financial Position

The company has a current ratio of 0.67, with a Debt / Equity ratio of 0.30.

Current Ratio	0.67
Quick Ratio	0.33
Debt / Equity	0.30
Debt / EBITDA	n/a
Debt / FCF	-3.75
Interest Coverage	-86.80

Financial Efficiency

Return on equity (ROE) is -27.42% and return on invested capital (ROIC) is -11.07%.

Return on Equity (ROE)	-27.42%
Return on Assets (ROA)	-9.41%
Return on Invested Capital (ROIC)	-11.07%
Return on Capital Employed (ROCE)	-19.97%
Revenue Per Employee	566.37M
Profits Per Employee	-175.94M
Employee Count	245
Asset Turnover	0.22
Inventory Turnover	1.70

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.97% in the last 52 weeks. The beta is 0.41, so KRX:007460's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-38.97%
50-Day Moving Average	705.14
200-Day Moving Average	964.73
Relative Strength Index (RSI)	57.30
Average Volume (20 Days)	1,656,712

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:007460 had revenue of KRW 138.76 billion and -43.10 billion in losses. Loss per share was -159.92.

Revenue	138.76B
Gross Profit	34.09B
Operating Income	-94.82B
Pretax Income	-110.32B
Net Income	-43.10B
EBITDA	-70.18B
EBIT	-94.82B
Loss Per Share	-159.92

Full Income Statement

Balance Sheet

The company has 43.62 billion in cash and 124.06 billion in debt, giving a net cash position of -80.43 billion or -276.33 per share.

Cash & Cash Equivalents	43.62B
Total Debt	124.06B
Net Cash	-80.43B
Net Cash Per Share	-276.33
Equity (Book Value)	416.12B
Book Value Per Share	513.03
Working Capital	-66.08B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -18.34 billion and capital expenditures -14.76 billion, giving a free cash flow of -33.09 billion.

Operating Cash Flow	-18.34B
Capital Expenditures	-14.76B
Free Cash Flow	-33.09B
FCF Per Share	-113.70

Full Cash Flow Statement

Margins

Gross margin is 24.57%, with operating and profit margins of -68.33% and -31.06%.

Gross Margin	24.57%
Operating Margin	-68.33%
Pretax Margin	-79.51%
Profit Margin	-31.06%
EBITDA Margin	-50.58%
EBIT Margin	-68.33%
FCF Margin	n/a

Dividends & Yields

KRX:007460 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.95%
Shareholder Yield	n/a
Earnings Yield	-20.83%
FCF Yield	-15.99%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 28, 2022. It was a reverse split with a ratio of 0.3333333333.

Last Split Date	Dec 28, 2022
Split Type	Reverse
Split Ratio	0.3333333333

Scores

KRX:007460 has an Altman Z-Score of -0.56. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.56
Piotroski F-Score	n/a